Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Harry Erba, MD, PhD, Duke University, Durham, NC; Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY; Thomas Cluzeau, MD, PhD, Central University Hospital…
NEW YORK (Reuters Health) – Oral sucrose remains effective over time for easing pain associated with repeated heel sticks in preterm infants, a new study shows. “Facilitated tucking”…
NEW YORK (Reuters Health) – In children with intestinal failure who are dependent on parenteral nutrition through an indwelling central venous catheter, the use of ethanol locks rather…
NEW YORK (Reuters Health) – Compared to other anticoagulants or placebo, the use of dabigatran for various clinical indications is associated with an increased risk of acute coronary…
NEW YORK (Reuters Health) – While first-void urine specimens have been used traditionally to test for Chlamydia trachomatis, newer DNA detection methods produce reliable results using midstream specimens,…
NEW YORK (Reuters Health) – Long-term inhalation therapy with dry-powder mannitol improves lung function in patients with cystic fibrosis (CF), a multinational team reports in the American Journal…
NEW YORK (Reuters Health) – While observational data indicate that closure of a patent foramen ovale (PFO) is better than medical therapy in preventing stroke recurrence, the results…
NEW YORK (Reuters Health) – For primary percutaneous coronary intervention for ST-segment elevation MI, access via the radial artery is associated with better outcomes than is the femoral…
NEW YORK (Reuters Health) – Patients with focal forms of congenital hyperinsulinism are likely to be cured of hypoglycemia after partial pancreatectomy, clinicians from France report in the…
NEW YORK (Reuters Health) – Patients with HIV infection who are admitted to the hospital with acute coronary syndrome (ACS) face a “substantial” risk of dying in the…
NEW YORK (Reuters Health) – In a phase 2 study of maintenance therapy for metastatic colorectal cancer, adding enzastaurin to bevacizumab plus bolus and infusional 5-fluorouracil-leucovorin (LV5FU2) did…
